Published in Nat Neurosci on August 01, 1998
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol (2006) 4.60
Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry (2006) 3.97
A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci (2011) 3.23
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) (2004) 3.11
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A (2005) 2.68
A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci (2009) 2.54
The schizophrenia risk gene product miR-137 alters presynaptic plasticity. Nat Neurosci (2015) 2.37
Continuation of neurogenesis in the hippocampus of the adult macaque monkey. Proc Natl Acad Sci U S A (1999) 2.33
Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron (2013) 2.32
Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry (2009) 2.25
Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. Am J Psychiatry (2014) 2.21
Prefrontal cortex and episodic memory retrieval mode. Proc Natl Acad Sci U S A (2000) 1.80
Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci (2008) 1.73
The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. Proc Natl Acad Sci U S A (2005) 1.71
Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry (2008) 1.70
Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry (2004) 1.64
Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia. Mol Psychiatry (2013) 1.61
Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology (2011) 1.59
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther (2003) 1.57
Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci (2011) 1.57
The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol Psychiatry (2008) 1.55
Prefrontal activation deficits during episodic memory in schizophrenia. Am J Psychiatry (2009) 1.53
Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci (2011) 1.49
Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognition. Am J Psychiatry (2005) 1.47
Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neurosci (2009) 1.43
Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res (2007) 1.42
Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry (2015) 1.40
New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats. Neuropharmacology (2011) 1.37
Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. Am J Psychiatry (2001) 1.35
Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology (2010) 1.34
Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism. Int Rev Psychiatry (2007) 1.32
The influence of encoding strategy on episodic memory and cortical activity in schizophrenia. Biol Psychiatry (2005) 1.32
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci U S A (2013) 1.31
Identification of the hippocampal input to medial prefrontal cortex in vitro. Cereb Cortex (2009) 1.28
Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia. Neuropsychopharmacology (2002) 1.26
Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives. Schizophr Bull (2008) 1.24
Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry (2001) 1.23
Evidence for anomalous network connectivity during working memory encoding in schizophrenia: an ICA based analysis. PLoS One (2009) 1.22
Vasopressin 1b receptor knock-out impairs memory for temporal order. J Neurosci (2009) 1.22
Are we studying and treating schizophrenia correctly? Schizophr Res (2011) 1.19
Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs. J Neurosci (2012) 1.18
Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia. J Neurosci (2011) 1.18
Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (2015) 1.14
A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia. Biol Psychiatry (2010) 1.13
An fMRI study of semantic processing in men with schizophrenia. Neuroimage (2003) 1.12
Baseline gamma power during auditory steady-state stimulation in schizophrenia. Front Hum Neurosci (2012) 1.11
Dopamine modulation of hippocampal-prefrontal cortical interaction drives memory-guided behavior. Cereb Cortex (2007) 1.11
Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl) (2006) 1.10
Eye-movement behavior reveals relational memory impairment in schizophrenia. Biol Psychiatry (2010) 1.08
Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia. J Neurosci (2012) 1.07
CNTRICS final task selection: long-term memory. Schizophr Bull (2008) 1.06
Differential activation patterns of occipital and prefrontal cortices during motion processing: evidence from normal and schizophrenic brains. Cogn Affect Behav Neurosci (2008) 1.05
Memory, consciousness and neuroimaging. Philos Trans R Soc Lond B Biol Sci (1998) 1.04
Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia. Schizophr Res (2009) 1.04
Npas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders. PLoS One (2012) 1.03
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals. Schizophr Bull (2012) 1.03
Task-dependent modulations of prefrontal and hippocampal activity during intrinsic word production. J Cogn Neurosci (2009) 1.01
Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophr Bull (2012) 1.01
Reinforcement ambiguity and novelty do not account for transitive inference deficits in schizophrenia. Schizophr Bull (2009) 1.01
Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol (2011) 1.00
Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci U S A (2008) 1.00
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) (2011) 0.99
Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res (2008) 0.99
Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2006) 0.98
GABAergic mechanisms of hippocampal hyperactivity in schizophrenia. Schizophr Res (2014) 0.98
NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus. J Neurophysiol (2012) 0.98
Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb Cortex (2004) 0.97
Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis. Schizophr Bull (2009) 0.97
Neuroimaging biomarkers for early drug development in schizophrenia. Biol Psychiatry (2013) 0.95
Using computational patients to evaluate illness mechanisms in schizophrenia. Biol Psychiatry (2011) 0.95
Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms. JAMA Psychiatry (2016) 0.94
Multivariate pattern analysis of functional magnetic resonance imaging data reveals deficits in distributed representations in schizophrenia. Biol Psychiatry (2008) 0.94
Developmental pathology, dopamine, stress and schizophrenia. Int J Dev Neurosci (2010) 0.93
Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues Clin Neurosci (2010) 0.93
Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study. J Psychiatry Neurosci (2012) 0.93
The role of the hippocampus in flexible cognition and social behavior. Front Hum Neurosci (2014) 0.93
Hippocampal shape abnormalities of patients with childhood-onset schizophrenia and their unaffected siblings. J Am Acad Child Adolesc Psychiatry (2013) 0.92
Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction. Schizophr Res (2014) 0.91
A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia. Transl Psychiatry (2013) 0.91
Memory generalization is selectively altered in the psychosis dimension. Schizophr Res (2012) 0.90
Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia. Int J Neuropsychopharmacol (2012) 0.90
Functional magnetic resonance imaging of internal source monitoring in schizophrenia: recognition with and without recollection. Schizophr Res (2006) 0.90
A comprehensive analysis of NDST3 for schizophrenia and bipolar disorder in Han Chinese. Transl Psychiatry (2016) 0.89
Stochastic tractography study of Inferior Frontal Gyrus anatomical connectivity in schizophrenia. Neuroimage (2011) 0.89
The effect of distracting noise on the neuronal mechanisms of attention in schizophrenia. Schizophr Res (2012) 0.89
Anomalous neural circuit function in schizophrenia during a virtual Morris water task. Neuroimage (2009) 0.89
Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: implications for pursuit eye tracking. Psychiatry Res (2011) 0.88
Regulation of synaptic plasticity in a schizophrenia model. Proc Natl Acad Sci U S A (2005) 0.88
Increased hippocampal CA1 cerebral blood volume in schizophrenia. Neuroimage Clin (2014) 0.87
Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). Schizophr Bull (2014) 0.87
Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation. Front Psychiatry (2014) 0.87
Impaired associative learning in schizophrenia: behavioral and computational studies. Cogn Neurodyn (2008) 0.87
Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function. Schizophr Bull (2007) 0.86
Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion. Mol Cell Neurosci (2011) 0.86
Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations. J Psychiatry Neurosci (2011) 0.86
Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia. Cereb Cortex (2012) 0.86
The effect of neurogranin on neural correlates of episodic memory encoding and retrieval. Schizophr Bull (2011) 0.86
An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia. Dev Neurobiol (2014) 0.86
Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task. Psychopharmacology (Berl) (2005) 0.85
Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J Biol Chem (1972) 10.86
Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci (1998) 7.85
Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science (1998) 7.58
Response and habituation of the human amygdala during visual processing of facial expression. Neuron (1996) 5.93
Top-down facilitation of visual recognition. Proc Natl Acad Sci U S A (2006) 5.38
The primary structure of epidermal growth factor. J Biol Chem (1972) 4.41
Priming and human memory systems. Science (1990) 4.19
The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry (1998) 3.20
A functional MRI study of human amygdala responses to facial expressions of fear versus anger. Emotion (2001) 3.15
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biol Psychiatry (2001) 2.95
Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry (1999) 2.95
Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet (2000) 2.95
Toward a neurobiology of obsessive-compulsive disorder. Neuron (2000) 2.89
The role of area 17 in visual imagery: convergent evidence from PET and rTMS. Science (1999) 2.78
Cortical mechanisms specific to explicit visual object recognition. Neuron (2001) 2.77
Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry (1994) 2.70
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry (2000) 2.68
Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging (1995) 2.62
Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli. Neuroreport (2001) 2.60
The counting Stroop: an interference task specialized for functional neuroimaging--validation study with functional MRI. Hum Brain Mapp (1998) 2.52
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 2.49
Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related PTSD: A PET investigation. Am J Psychiatry (1999) 2.35
Differential response in the human amygdala to racial outgroup vs ingroup face stimuli. Neuroreport (2000) 2.29
Implicit and explicit memory for new associations in normal and amnesic subjects. J Exp Psychol Learn Mem Cogn (1985) 2.27
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am (2000) 2.24
A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry (1996) 2.22
Do amnesics exhibit cognitive dissonance reduction? The role of explicit memory and attention in attitude change. Psychol Sci (2001) 2.18
Encoding novel face-name associations: a functional MRI study. Hum Brain Mapp (2001) 2.13
Conscious recollection and the human hippocampal formation: evidence from positron emission tomography. Proc Natl Acad Sci U S A (1996) 2.09
Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing. Cancer J Sci Am (2006) 2.04
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry (1999) 2.03
Prefrontal contributions to executive control: fMRI evidence for functional distinctions within lateral Prefrontal cortex. Neuroimage (2001) 2.02
When magic bullets ricochet. J Nucl Med (1990) 2.01
Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci U S A (1991) 2.00
Topographical representations of mental images in primary visual cortex. Nature (1995) 1.93
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med (1990) 1.92
The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses. Psychother Psychosom (1995) 1.92
Epidermal growth factor. Location of disulfide bonds. J Biol Chem (1973) 1.90
Priming of semantic autobiographical knowledge: a case study of retrograde amnesia. Brain Cogn (1988) 1.83
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med (1994) 1.80
High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res (2000) 1.80
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Can medial temporal lobe regions distinguish true from false? An event-related functional MRI study of veridical and illusory recognition memory. Proc Natl Acad Sci U S A (2001) 1.76
111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med (1989) 1.76
Obese children show hyperactivation to food pictures in brain networks linked to motivation, reward and cognitive control. Int J Obes (Lond) (2010) 1.75
Perceptual specificity in visual object priming: functional magnetic resonance imaging evidence for a laterality difference in fusiform cortex. Neuropsychologia (2001) 1.74
Functional-anatomic study of episodic retrieval using fMRI. I. Retrieval effort versus retrieval success. Neuroimage (1998) 1.70
ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell (1990) 1.70
False recognition in younger and older adults: exploring the characteristics of illusory memories. Mem Cognit (1997) 1.69
The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience (2010) 1.69
Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies. J Clin Psychiatry (1994) 1.67
Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapp (1997) 1.65
Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation (1998) 1.64
Absence of explicit or implicit memory in patients anesthetized with sufentanil/nitrous oxide. Anesthesiology (1992) 1.61
Association between Stevens-Johnson syndrome and benoxaprofen. Br Med J (Clin Res Ed) (1981) 1.61
Influence of cardiac functional capacity on gender differences in maximal oxygen uptake in children. Chest (2000) 1.60
Endothelial leukocyte adhesion molecule 1: direct expression cloning and functional interactions. Proc Natl Acad Sci U S A (1990) 1.59
Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry (2001) 1.59
Functional MRI evidence for a role of frontal and inferior temporal cortex in amodal components of priming. Brain (2000) 1.58
Neural substrates of anorexia nervosa: a behavioral challenge study with positron emission tomography. J Pediatr (2001) 1.58
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry (1996) 1.56
Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother (1993) 1.55
Unawareness of deficits in neuropsychological syndromes. J Clin Exp Neuropsychol (1989) 1.55
Mental rotation of objects versus hands: neural mechanisms revealed by positron emission tomography. Psychophysiology (1998) 1.55
Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease. Neurosurgery (1996) 1.53
Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry (1997) 1.52
The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry (1997) 1.52
Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology (1992) 1.51
Task-specific repetition priming in left inferior prefrontal cortex. Cereb Cortex (2000) 1.50
Proceedings: Combined EEG recording and intraventricular administration of drugs in the conscious rat. Br J Pharmacol (1975) 1.48
Recent studies on the chemistry and biology of epidermal growth factor. Recent Prog Horm Res (1974) 1.48
A method for assessing the accuracy of intersubject registration of the human brain using anatomic landmarks. Neuroimage (1999) 1.48
Simplified measurement of deoxyglucose utilization rate. J Nucl Med (1996) 1.48
Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry (1997) 1.47
Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophr Res (2001) 1.46
Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases. J Clin Psychiatry (2001) 1.45
Conformation and unfolding thermodynamics of epidermal growth factor and derivatives. Biochemistry (1976) 1.43
Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism. J Nucl Med (1997) 1.42
Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial. Rapid Early Action for Coronary Treatment. Coron Artery Dis (2000) 1.38